Insider Transactions in Q1 2022 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-4.76%
|
$5,250,000
$105.06 P/Share
|
|
Mar 25
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-4.46%
|
$2,725,000
$109.37 P/Share
|
|
Mar 25
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.27%
|
$550,000
$22.14 P/Share
|
|
Mar 25
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
663
-0.42%
|
$72,930
$110.0 P/Share
|
|
Mar 24
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
1,481
-0.92%
|
$162,910
$110.0 P/Share
|
|
Mar 23
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
11,699
-6.79%
|
$1,286,890
$110.01 P/Share
|
|
Mar 23
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
26,090
-96.13%
|
$2,869,900
$110.0 P/Share
|
|
Mar 23
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,090
+49.01%
|
$391,350
$15.96 P/Share
|
|
Mar 18
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,531
+13.95%
|
$187,682
$22.14 P/Share
|
|
Mar 11
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.25%
|
$2,525,000
$101.07 P/Share
|
|
Mar 11
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.27%
|
$550,000
$22.14 P/Share
|
|
Mar 10
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
8,169
+13.37%
|
-
|
|
Mar 10
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
8,169
-15.63%
|
-
|
|
Mar 07
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Bona fide gift
|
Indirect |
238,852
+35.69%
|
-
|
|
Mar 07
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Indirect |
172,226
-70.29%
|
-
|
|
Mar 07
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Direct |
66,626
-98.45%
|
-
|
|
Mar 02
2022
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
35,000
-13.63%
|
$3,395,000
$97.24 P/Share
|
|
Feb 28
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-2.19%
|
$4,600,000
$92.01 P/Share
|
|
Feb 25
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-4.09%
|
$2,300,000
$92.51 P/Share
|
|
Feb 25
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.93%
|
$550,000
$22.14 P/Share
|
|
Feb 18
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,313
-3.2%
|
$123,422
$94.82 P/Share
|
|
Feb 11
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.06%
|
$2,425,000
$97.53 P/Share
|
|
Feb 11
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.93%
|
$550,000
$22.14 P/Share
|
|
Feb 01
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,767
-8.43%
|
$354,098
$94.33 P/Share
|
|
Feb 01
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,087
+16.9%
|
-
|
|
Jan 31
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
100,000
-5.02%
|
$9,100,000
$91.77 P/Share
|
|
Jan 28
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-3.52%
|
$2,250,000
$90.0 P/Share
|
|
Jan 28
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.4%
|
$550,000
$22.14 P/Share
|
|
Jan 21
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,009
-1.3%
|
$774,774
$86.42 P/Share
|
|
Jan 21
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,336
+2.84%
|
-
|
|
Jan 21
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,372
-3.85%
|
$203,992
$86.42 P/Share
|
|
Jan 21
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,354
+7.99%
|
-
|
|
Jan 21
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,463
-3.51%
|
$211,818
$86.42 P/Share
|
|
Jan 21
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,558
+7.34%
|
-
|
|
Jan 21
2022
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,825
-1.31%
|
$156,950
$86.42 P/Share
|
|
Jan 21
2022
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,679
+2.57%
|
-
|
|
Jan 14
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-3.58%
|
$2,250,000
$90.02 P/Share
|
|
Jan 14
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.45%
|
$550,000
$22.14 P/Share
|
|
Jan 06
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
7,987
-4.2%
|
$782,726
$98.93 P/Share
|
|
Jan 05
2022
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,841
-26.51%
|
$5,033,941
$101.84 P/Share
|
|
Jan 05
2022
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,375
+20.13%
|
-
|
|
Jan 05
2022
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,959
+31.6%
|
-
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,636
-9.27%
|
$367,236
$101.84 P/Share
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,043
+17.01%
|
-
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
174,906
-20.6%
|
$17,665,506
$101.84 P/Share
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
152,896
+15.26%
|
-
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
241,750
+25.77%
|
-
|
|
Jan 05
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,675
-40.09%
|
-
|
|
Jan 05
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,301
+25.58%
|
-
|
|
Jan 05
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,570
+46.01%
|
-
|